Skip to main content
SpringerLink
Log in
Book cover

Photodynamic Therapy in Dermatology pp 77–82Cite as

Methyl Aminolevulinate in Skin Cancers

  • Chapter
  • First Online:

  • 1127 Accesses

Abstract

Methyl aminolevulinate (MAL) is registered in several countries worldwide not only for PDT of actinic keratoses but also for superficial and nodular basal cell carcinoma (sBCC & nBCC) and Bowen’s disease. In the following chapter, evidence-based data of MAL-PDT for epithelial skin cancer are reviewed and further use of MAL-PDT is discussed. Cure rates for sBCC and nBCC are comparable to that of other nonsurgical procedures, whereas MAL-PDT for Bowen’s disease is as effective as conventional surgery or application of topical 5-FU or cryotherapy, but with much better cosmesis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Babilas P, Schreml S, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed. 2010;26:118–32.

    Article  PubMed  CAS  Google Scholar 

  2. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol. 2007;156:793–801.

    Article  PubMed  CAS  Google Scholar 

  3. Christensen E, Warloe T, Kroon S, et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol. 2010;24:505–12.

    Article  PubMed  CAS  Google Scholar 

  4. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol. 2001;145:467–71.

    Article  PubMed  CAS  Google Scholar 

  5. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001;137:319–24.

    PubMed  CAS  Google Scholar 

  6. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol. 2003;149:1242–9.

    Article  PubMed  CAS  Google Scholar 

  7. Rhodes LE, de Rie M, Enstrom Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs. surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140:17–23.

    Article  PubMed  CAS  Google Scholar 

  8. Wang I, Bendsoe N, Klinteberg CA, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol. 2001;144:832–40.

    Article  PubMed  CAS  Google Scholar 

  9. Basset-Seguin N, Ibbotson SH, Emtestam L, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol. 2008;18:547–53.

    PubMed  CAS  Google Scholar 

  10. Foley P, Freeman M, Menter A, et al. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol. 2009;48:1236–45.

    Article  PubMed  CAS  Google Scholar 

  11. Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol. 2003;39:1133–6.

    Article  PubMed  CAS  Google Scholar 

  12. Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolog Treat. 2003;14 Suppl 3:15–22.

    PubMed  CAS  Google Scholar 

  13. Szeimies RM, Ibbotson S, Murrell DF, et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol. 2008;22: 1302–11.

    Article  PubMed  CAS  Google Scholar 

  14. Caekelbergh K, Nikkels AF, Leroy B, et al. Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes. J Drugs Dermatol. 2009;8:992–6.

    PubMed  Google Scholar 

  15. Fai D, Arpaia N, Romano I, et al. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. G Ital Dermatol Venereol. 2009;144:281–5.

    PubMed  CAS  Google Scholar 

  16. Haedersdal M, Sakamoto FH, Farinelli WA, et al. Fractional CO2 laser-assisted drug delivery. Lasers Surg Med. 2010;42:113–22.

    Article  PubMed  Google Scholar 

  17. Clementoni MT, Roscher M, Munavalli GS. Photodynamic photorejuvenation of the face with a combination of microneedling, red light, and broadband pulsed light. Lasers Surg Med. 2010;42:150–9.

    Article  PubMed  Google Scholar 

  18. Pye A, Campbell S, Curnow A. Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma. J Cancer Res Clin Oncol. 2008;134:841–9.

    Article  PubMed  CAS  Google Scholar 

  19. Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen’s disease: 2006 update. Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Br J Dermatol. 2007;156:11–21.

    Article  PubMed  CAS  Google Scholar 

  20. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international ­consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56:125–43.

    Article  PubMed  Google Scholar 

  21. Morton CA, McKenna KE. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159:1245–66.

    Article  PubMed  CAS  Google Scholar 

  22. Morton C, Horn M, Leman J, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol. 2006;142:729–35.

    Article  PubMed  CAS  Google Scholar 

  23. Morton CA. Methyl aminolevulinate: actinic keratoses and Bowen’s disease. Dermatol Clin. 2007;25:81–7.

    Article  PubMed  CAS  Google Scholar 

  24. Calzavara-Pinton PG, Venturini M, Sala R, et al. Methylaminolaevulinate-based photodynamic therapy of Bowen’s disease and squamous cell carcinoma. Br J Dermatol. 2008;159:137–44.

    Article  PubMed  CAS  Google Scholar 

  25. Zane C, Venturini M, Sala R, Calzavara-Pinton P. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed. 2006;22:254–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Allergology, Klinikum Vest Academic Teaching Hospital, 45657, Recklinghausen, Germany

    Rolf-Markus Szeimies

  2. Department of Dermatology, Regensburg University Hospital, 93042, Regensburg, Germany

    Rolf-Markus Szeimies

Authors
  1. Rolf-Markus Szeimies
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philipp Babilas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rolf-Markus Szeimies .

Editor information

Editors and Affiliations

  1. Gold Skin Care Center, Tennessee Clinical Research Center, Dermatologic and Cosmetic Surgeon, Vanderbilt University School of Nursing, Nashville, 37215, Tennessee, USA

    Michael H. Gold

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Szeimies, RM., Babilas, P. (2011). Methyl Aminolevulinate in Skin Cancers. In: Gold, M. (eds) Photodynamic Therapy in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1298-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1298-5_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1297-8

  • Online ISBN: 978-1-4419-1298-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation